Hengeler Mueller advises MeVis on domination and profit and loss transfer agreement with VMS Deutschland Holdings GmbH

30. September 2015

On 29 September 2015, the extraordinary general meeting of MeVis Medical Solutions AG (MeVis) resolved to approve a domination and profit and loss transfer agreement between MeVis as the controlled company and VMS Deutschland Holdings GmbH (VMS) as the controlling company. VMS, an indirect subsidiary of Varian Medical Systems, Inc., had published a voluntary takeover offer to the shareholders of MeVis on 27 January 2015. Based on the takeover offer, VMS holds around 73.52% in MeVis.

MeVis, headquartered in Bremen, was founded in 1997 and is one of the world's leading independent developers and providers of medical imaging software with focus on dedicated, disease-oriented clinical applications. MeVis has been listed on the Frankfurt Stock Exchange in the Prime Standard segment at the regulated market since 16 November 2007.

Hengeler Mueller advised MeVis on the conclusion of the domination and profit and loss transfer agreement and on the preparation and implementation of the extraordinary general meeting. The Hengeler Mueller team included partners Oliver Rieckers and Gerd Krieger as well as associate Henning Geerken (all Corporate, Düsseldorf).